These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37233423)
1. Identification of the active ingredients and pharmacological effects of Kuntai capsules in the treatment of primary ovarian insufficiency: A review. Liu FX; Sun Y Medicine (Baltimore); 2023 May; 102(21):e33884. PubMed ID: 37233423 [TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic drug targets and pathways prediction for premature ovarian insufficiency -Based on network pharmacologic method. Ju S; He J; Wang H; Yang L; Guo A; Guo Y; Qi M; Wang H; Ai L J Ethnopharmacol; 2023 Mar; 304():116054. PubMed ID: 36526095 [TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency. Cao Y; Chen Y; Wang P; Lu J; Han X; She J Bioengineered; 2021 Dec; 12(2):10345-10362. PubMed ID: 34753385 [TBL] [Abstract][Full Text] [Related]
4. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer. Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733 [TBL] [Abstract][Full Text] [Related]
5. Kuntai capsule attenuates premature ovarian insufficiency by activating the FOXO3/SIRT5 signaling pathway in mice: A comprehensive study using UHPLC-LTQ-Orbitrap and integrated pharmacology. Gong L; Hou J; Yang H; Zhang X; Zhao J; Wang L; Yin X; Feng X; Yin C J Ethnopharmacol; 2024 Mar; 322():117625. PubMed ID: 38145859 [TBL] [Abstract][Full Text] [Related]
6. Potential molecular mechanism of the Xiexin capsule in the intervention of dyslipidemia based on bioinformatics and molecular docking. Yao K; Cai H; Wang Y; Cheng S; Liu Q; Zhang D; Chen Q; Chen X Nutr Hosp; 2022 Jun; 39(3):569-579. PubMed ID: 35227068 [TBL] [Abstract][Full Text] [Related]
7. Network pharmacology-based and molecular docking prediction of the active ingredients and mechanism of ZaoRenDiHuang capsules for application in insomnia treatment. Jin D; Zhang J; Zhang Y; An X; Zhao S; Duan L; Zhang Y; Zhen Z; Lian F; Tong X Comput Biol Med; 2021 Aug; 135():104562. PubMed ID: 34174759 [TBL] [Abstract][Full Text] [Related]
8. Understanding the mechanism of twenty-five ingredient decoction for setting a fracture in the treatment of fractures based on network pharmacology. Tian Z; Hao Y; Wang M; Li Y; Cui K; Hou P; Wang X; Lv D; Shi J Medicine (Baltimore); 2023 Feb; 102(5):e32864. PubMed ID: 36749277 [TBL] [Abstract][Full Text] [Related]
9. Network pharmacology and transcriptomics analysis reveal the mechanism of BushenHuoxue formula attenuates premature ovarian failure via modulation PI3K/AKT pathway. Zhao W; Chen Y; He J; Chen S; Shen J; Jiao B; Li T; Su M; Mao T; Wang P Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):226-232. PubMed ID: 38814209 [TBL] [Abstract][Full Text] [Related]
10. Qilin Pill Exerts Therapeutic Effect on Resection-Induced Premature Ovarian Insufficiency Rats by Inhibiting the MAPK and PI3K-AKT Signaling Pathways. Li D; Jia Y; Hou Y; Chen D; Zheng C; Chen L; Zhou L; Sun Z Drug Des Devel Ther; 2021; 15():3331-3345. PubMed ID: 34354343 [TBL] [Abstract][Full Text] [Related]
11. Study on the mechanism of Baihe Dihuang decoction in treating menopausal syndrome based on network pharmacology. Tian M; Yang A; Lu Q; Zhang X; Liu G; Liu G Medicine (Baltimore); 2023 May; 102(20):e33189. PubMed ID: 37335709 [TBL] [Abstract][Full Text] [Related]
12. Analyzing network pharmacology and molecular docking to clarify Duhuo Jisheng decoction potential mechanism of osteoarthritis mitigation. Cui Z; Zhang W; Le X; Song K; Zhang C; Zhao W; Sha L Medicine (Baltimore); 2022 Dec; 101(50):e32132. PubMed ID: 36550856 [TBL] [Abstract][Full Text] [Related]
13. Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy. Lin Y; Shen C; Wang F; Fang Z; Shen G J Diabetes Res; 2021; 2021():9941791. PubMed ID: 34159207 [TBL] [Abstract][Full Text] [Related]
14. [Mechanism of Marsdenia tenacissima against ovarian cancer based on network pharmacology and experimental verification]. Hu YJ; Wei LY; Zhao J; Zhu QF; Meng ZY; Meng JJ; Chen JJ; Xu LY; Zhou YY; Han YL Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2222-2232. PubMed ID: 37282910 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of the Bushen Huoxue formula in the treatment of osteoarthritis based on network pharmacology-molecular targets. Pang T; Liu C; Yao J; Li J; Li Z; Lou H; Lei S; Zhang J; Dong L; Wang Y Medicine (Baltimore); 2022 Aug; 101(32):e29345. PubMed ID: 35960090 [TBL] [Abstract][Full Text] [Related]
16. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking. Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308 [TBL] [Abstract][Full Text] [Related]
17. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking. Wu Z; Ji X; Shan C; Song J; Zhao J Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the Mechanism of Action of Kushen in the Treatment of Tuberculosis Based on Network Pharmacology. Lin M; Zhou H; Li R; Quan LL; Jin Z; Tong XW Altern Ther Health Med; 2023 Mar; 29(2):155-161. PubMed ID: 36455142 [TBL] [Abstract][Full Text] [Related]
19. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking. Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376 [TBL] [Abstract][Full Text] [Related]
20. A network pharmacology approach to explore active compounds and pharmacological mechanisms of epimedium for treatment of premature ovarian insufficiency. Zhao H; Shan Y; Ma Z; Yu M; Gong B Drug Des Devel Ther; 2019; 13():2997-3007. PubMed ID: 31692519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]